| 148591 |
|
Fourcroy J. |
Pharmacology, Doping and Sports: A Scientific Guide for Athletes, Coaches, Physicians, Scientists and Administrators |
2009 | •• |
| 58578 |
|
Anthony P.K. |
Pharmacology Secrets |
2002 | •• |
| 75622 |
|
Davis F.A. |
Pharmacology in Rehabilitation Ciccone |
2007 • | •• |
| 46309 |
|
Asghar K. (ed.), De Souza E. (ed.) |
Pharmacology And Toxicology of Amphetamine And Related Designer Drugs |
1989 | •• |
| 83865 |
|
Chung K.F., Widdicombe J.G. |
Pharmacology and therapeutics of cough |
2008 | •• |
| 150311 |
|
Kian Fan Chung, Peter J. Barnes |
Pharmacology and Therapeutics of Airway Disease, Second Edition, Volume 234 (Lung Biology in Health and Disease) |
2009 • | •• |
| 144695 |
|
Ward D.S., Dahan A., Teppema L. |
Pharmacology and Pathophysiology of the Control of Breathing |
2005 | •• |
| 48035 |
|
Rang H.P., Ritter J.M. |
Pharmacology |
2005 • | •• |
| 49607 |
|
Welling P.G. (ed.), Tse F.L. (ed.) |
Pharmacokinetics: Regulatory - Industrial - Academic Perspectives |
1995 • | •• |
| 48028 |
|
Schoenwald R.D. (ed.) |
PharmacoKinetics in Drug Discovery and Development |
2002 • | •• |
| 187735 |
|
Meibohm B. |
Pharmacokinetics and Pharmacodynamics of Biotech Drugs: Principles and Case Studies in Drug Development |
2006 | •• |
| 188383 |
|
Smith D., Waterbeemd H., Walker D. |
Pharmacokinetics and Metabolism in Drug Design, Second Revised Edition |
2006 | •• |
| 16293 |
|
Smith D.A., van de Waterbeemd H., Walker D.K. |
Pharmacokinetics and Metabolism in Drug Design |
2001 | •• |
| 188148 |
|
Smith D., Waterbeemd H., Walker D. |
Pharmacokinetics and Metabolism in Drug Design |
2001 | •• |
| 84403 |
|
Bonate P.L. |
Pharmacokinetic-pharmacodynamic modeling and simulation |
2005 | •• |
| 84173 |
|
Testa B., Krämer S.D., Wunderli-Allenspach H. |
Pharmacokinetic profiling in drug research: biological, physicochemical, and computational strategies |
2006 | •• |
| 182542 |
|
Testa B., Waterbeemd H., Folkers G. |
Pharmacokinetic Optimization in Drug Research: Biological, Physicochemical, and Computational Strategies |
2001 | •• |
| 163867 |
|
Kar A. |
Pharmacognosy and Pharmaco-biotechnology, Second Revised and Expanded Edition |
2008 • | •• |
| 17335 |
|
Licinio J., Wong M.-L. (eds.) |
Pharmacogenomics: The Search for Individualized Therapies |
2002 | •• |
| 16292 |
|
Rothstein M.A. |
Pharmacogenomics: Social, Ethical, and Clinical Dimensions |
2003 | •• |
| 152228 |
|
Federico Innocenti |
Pharmacogenomics: Methods and Protocols (Methods in Molecular Biology) |
2005 • | •• |
| 154418 |
|
Innocenti F. |
Pharmacogenomics. Methods and Protocols |
2005 | •• |
| 144088 |
|
Yan Q. |
Pharmacogenomics in Drug Discovery and Development |
2008 | •• |
| 191193 |
|
Yan Q. |
Pharmacogenomics in Drug Discovery and Development |
2008 | •• |
| 8763 |
|
Weber W.W., Cronin M.T. |
Pharmacogenetic Testing |
2000 | •• |
| 17022 |
|
Strom B.L. (ed.) |
Pharmacoepidemiology |
2000 • | •• |
| 48027 |
|
Taylor D. (ed.), Knapp M. (ed.), Kerwin R. (ed.) |
Pharmacoeconomics in Psychiatry |
2002 • | •• |
| 49606 |
|
Kümmerer K. |
Pharmaceuticals in the Environment: Source, Fate, Effects and Risk |
2008 • | •• |
| 186750 |
|
Avis K., Shukla A., Chang R. |
Pharmaceutical unit operations : coating |
1998 | •• |
| 140503 |
|
Wells J.I., Rubinstein M.H. |
Pharmaceutical Technology. Controlled Drug Release. Volume 2 |
1991 | •• |
| 54197 |
|
Kleemann A., Engel J. |
Pharmaceutical Substances: Syntheses, Patents, Applications |
2001 • | •• |
| 161007 |
|
Kim Huynh-Ba |
Pharmaceutical Stability Testing to Support Global Markets (Biotechnology: Pharmaceutical Aspects) |
2009 • | •• |
| 17021 |
|
Office of Technology Assessment |
Pharmaceutical R And D: Costs, Risks And Rewards |
2005 | •• |
| 161718 |
|
Cartwright A. |
Pharmaceutical Product Licensing: Requirements For Europe (Ellis Horwood Books in the Biological Sciences) |
1991 | •• |
| 49603 |
|
Chilukuri D.M. (ed.), Young D. (ed.), Sunkara G. (ed.) |
Pharmaceutical Product Development: In Vitro-In Vivo Correlation |
2006 | •• |
| 48026 |
|
Gibson M. (ed.) |
Pharmaceutical Preformulation and Formulation: A Practical Guide from Candidate Drug Selection to Commercial Dosage Form |
2004 • | •• |
| 48025 |
|
Hynes M.D. (ed.) |
Pharmaceutical Pre-Approval Inspections: A Guide to Regulatory Success |
2008 • | •• |
| 126668 |
|
Piechocki J.T., Thoma K. |
Pharmaceutical Photostability and Stabilization Technology |
2006 | •• |
| 83998 |
|
Mahato R.I. (ed.), Kim S.W. (ed.) |
Pharmaceutical perspectives of nucleic acid-based therapeutics |
2002 • | •• |
| 84120 |
|
Dean D.A. |
Pharmaceutical packaging technology |
2000 | •• |
| 35656 |
|
McCarron P.A., Hall M. |
Pharmaceutical Nanotechnology |
2004 | •• |
| 128152 |
|
Hugo W.B., Russell A.D. |
Pharmaceutical Microbiology |
1998 • | •• |
| 158304 |
|
Kar A. |
Pharmaceutical Microbiology |
2008 | •• |
| 146218 |
|
Goldberg R., Lonbay J. |
Pharmaceutical Medicine, Biotechnology and European Law |
2001 | •• |
| 48024 |
|
Haider S.I. |
Pharmaceutical Master Validation Plan: The Ultimate Guide to FDA, GMP and GLP Compliance |
2001 • | •• |
| 77855 |
|
Sittig M. |
Pharmaceutical Manufacturing Encyclopedia (2 volume set) |
1988 • | •• |
| 49604 |
|
|
Pharmaceutical Manufacturing Encyclopedia |
2005 • | •• |
| 132310 |
|
Robert A. Nash, Alfred H. Wachter |
Pharmaceutical Inhalation Aerosol Technology |
2003 • | •• |
| 196234 |
|
I.Ghebre-Selassie |
PHARMACEUTICAL EXTRUSION TECHNOLOGY |
2003 | •• |
| 49602 |
|
Armstrong N.A., James K.C. |
Pharmaceutical Experimental Design And Interpretation |
1996 | •• |
|
|
Î ïðîåêòå